Trial site
John Theurer Cancer Center
- 17running trials
- 9closed trials
The trials here
What the 28 trials at this site are about, from their registry records.
- Conditions
- Bladder cancer6 trials
- Lung cancer6 trials
- Colorectal cancer5 trials
- Melanoma5 trials
- Multiple myeloma5 trials
- Ovarian cancer5 trials
- Kidney cancer4 trials
- Prostate cancer4 trials
- Triple-negative breast cancer4 trials
- Cervical cancer3 trials
- Endometrial cancer3 trials
- Gastric and oesophageal cancer3 trials
- and 17 more
- Phase
- Phase 38 trials
- Phase 27 trials
- Phase 1/26 trials
- Phase 15 trials
- Phase 2/31 trial
- Status
- Active, not recruiting9 trials
- Recruiting8 trials
- Completed5 trials
- Terminated4 trials
- Suspended2 trials
- Lead sponsor
- Hackensack Meridian Health3 trials
- Boehringer Ingelheim2 trials
- Bristol-Myers Squibb2 trials
- Regeneron Pharmaceuticals2 trials
- Affimed GmbH1 trial
- and 18 more
Running trials
Recruiting
Recruiting
Active, not recruiting
Safety and Tolerability of IPH4502 in Patients With Advanced Solid Tumors
Recruiting
Recruiting
Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
Active, not recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Study of CAbozantinib in Combination with AtezolizumaB for Muscle-Invasive BladdEr Cancer
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer3 recruiting
- Bladder cancer2 recruiting
- Colorectal cancer2 recruiting
- Melanoma2 recruiting
- Cervical cancer1 recruiting
- Childhood cancers1 recruiting
- Diffuse large B-cell lymphoma1 recruiting
- Gastric and oesophageal cancer1 recruiting
- Head and neck cancer1 recruiting
- Kidney cancer1 recruiting
- Liver and biliary tract cancer1 recruiting
- Multiple myeloma1 recruiting
- Ovarian cancer1 recruiting
- Pancreatic cancer1 recruiting
- Prostate cancer1 recruiting
- Triple-negative breast cancer1 recruiting
Closed trials
Recruiting
A Phase 1 Study of CTIM-76 in Patients With Recurring Ovarian Cancer and Other Advanced Solid Tumors
Completed
Terminated
Phase 2 Study of AFM13 in Combination With AB-101 in Subjects With R/R HL and CD30+ PTCL
Terminated
Completed
Completed
Terminated
A Study of Modakafusp Alfa on Adult Participants With Relapsed/Refractory Multiple Myeloma
Completed
Phase I Dose Escalation Study for VIP152 in Patients With Advanced Cancer
Completed
Site data: ClinicalTrials.govUpdated 13 Nov 2026